AEHR, the Fremont, California-based maker of wafer-level and package-level semiconductor test and burn-in systems used to stress-test chips for AI processors, data centers, and electric vehicles, was trading higher by about 4.39% on Friday. The stock changed hands near $51.32, up from a prior close of $49.16. The advance marked a partial recovery from the previous session, when the shares fell sharply alongside a broad sell-off in semiconductor stocks. Market participants attributed the rebound primarily to a sector-wide bounce in chip-equipment names rather than any single company-specific announcement.
The dominant catalyst behind Friday's price action was a recovery in semiconductor and chip-equipment stocks following a sharp, market-wide decline in the prior session. Semiconductor manufacturers and their equipment suppliers sold off heavily on Thursday, pressuring names across the test, inspection, and packaging supply chain. On Friday, risk appetite returned as investors reassessed the sell-off, with analysts describing the move as "reactionary" rather than a fundamental reset in AI-driven chip demand.
AEHR moved in sympathy with peers. Test and inspection providers such as Camtek and Cohu — which, like Aehr, sit at various stages of semiconductor manufacturing, from reliability testing to advanced packaging — also climbed, underscoring that the bounce was broad-based across the equipment segment rather than isolated to a single company.
Beneath the day-to-day trading swings, AEHR carries a fundamentally stronger narrative heading into this week's rebound. Earlier this week, the company reported record fiscal first-quarter revenue of $33.0 million, up roughly 200% year over year, and raised its full-year revenue outlook to $150 million — approximately triple the prior fiscal year's total. Bookings reached $46.7 million, producing a book-to-bill ratio near 1.4, while effective backlog climbed to about $109.3 million.
The company's FOX wafer-level and Sonoma package-level burn-in platforms are directly tied to demand for AI processors, accelerators, and data-center infrastructure. Management has highlighted expanding production demand from a lead AI-processor customer as well as progress with a major supplier of AI accelerators, CPUs, and network processors. This AI-linked growth story provides the fundamental support that helped shares stabilize and bounce once broader selling pressure eased.
The move in AEHR aligned closely with the broader semiconductor complex, which led the session's recovery after Thursday's rout. The stock's rebound came alongside gains in other chip-equipment and testing peers, indicating sector momentum rather than idiosyncratic news. Technically, the shares were working back toward levels they held before the sell-off, though they remained well below the week's earlier highs reached following the earnings report. The elevated volatility of recent sessions — including a double-digit percentage swing earlier in the week — reflects both the stock's sensitivity to AI-chip sentiment and its relatively modest trading float.
Investors will be watching whether the AI-driven demand that fueled the company's record quarter continues to convert backlog into revenue through the remainder of fiscal 2027. Key areas of focus include the pace of Sonoma system shipments to the lead hyperscale customer, the planned installation of a FOX-XP wafer-level burn-in cell in Taiwan in early calendar 2027, and any further progress on new customer qualifications. Broader sentiment toward AI capital spending and semiconductor valuations will also remain important, given how tightly the stock has traded with the sector. Risks include customer concentration, the timing of high-volume production decisions, and the potential for continued volatility if macroeconomic or geopolitical concerns resurface.
Tickeron's Trending AI Robots page showcases a curated selection of the platform's strongest-performing automated trading strategies under current market conditions. Tickeron offers hundreds of AI trading bots spanning thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. Only the bots demonstrating standout results in the prevailing environment are featured in this section, making it a useful starting point for traders seeking data-driven, algorithmic approaches to today's markets.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where AEHR declined for three days, in 263 of 315 cases, the price declined further within the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 69 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
AEHR moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
The Aroon Indicator for AEHR entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 56 cases where AEHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 32 of 38 cases over the following month. The odds of a continued upward trend are 84%.
Following a +14.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.314) is normal, around the industry mean (5.295). AEHR has a moderately low P/E Ratio (-213.739) as compared to the industry average of (64.950). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment